ArticleClinicoEconomics and outcomes research : CEOR2026
Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in Italy.
Valentina Perrone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.